Does raloxifene reduce postmenopausal women's risk of breast cancer?
Han
R K
RK
University of Toronto, Ontario.
Pimlott
N
N
Heisey
R
R
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000517:prevention & control*; D004311:Double-Blind Method; D004965:Estrogen Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D005194:Family Practice; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control; D017698:Postmenopause; D020849:Raloxifene Hydrochloride / Q000494:pharmacology* / Q000627:therapeutic use; D018570:Risk Assessment
D004965:Estrogen Antagonists; D020849:Raloxifene Hydrochloride